Search
Login
Register
Menu
BJH
Home
News
Newsroom
Links
CongressUpdate
Guidelines
Specials
Hematotrials
Patients
All
All
BJH articles
Blog articles
Specials
Search
Forgot Password?
Not a member yet? Register here
Home
/
General
/ Article: Nivolumab in patients with relapsed or refractory classical Hodgkin Lymphoma
“1 year subscription print edition of the Belgian Journal of Hematology (BJH)” has been added to your cart.
View cart
Article: Nivolumab in patients with relapsed or refractory classical Hodgkin Lymphoma
€
2.42
Article: Nivolumab in patients with relapsed or refractory classical Hodgkin Lymphoma quantity
Add to cart
SKU:
product-article-17993
Category:
General
Description
Description
Nivolumab in patients with relapsed or refractory classical Hodgkin Lymphoma
Related products
Article: Highlights in melanoma
€
2.42
Add to cart
Article: Highlights in breast cancer
€
2.42
Add to cart
Article: Highlights in urologic cancer
€
2.42
Add to cart
Article: Highlights in gynaecological cancers
€
2.42
Add to cart